SCHEMBL6359798

SCHEMBL6359798

O=C(O)Cc1nc(NCc2ccccn2)c2c(-c3ccc4c(c3)OCO4)csc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 2/20 0.48
DYRK1A Q13627 1/20 0.48
MAPK1 P28482 5/20 0.48
TNF P01375 2/20 0.48
NOD1 Q9Y239 2/20 0.48
RET P07949 1/20 0.46
FYN P06241 1/20 0.46
PIP4K2C Q8TBX8 1/20 0.44
LMNA P02545 3/20 0.43
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 6/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
TSHR P16473 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
MEN1 O00255 2/20 0.43
MAPT P10636 2/20 0.43
KMT2A Q03164 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
TP53 P04637 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2368803 0.91 CLK4 (0.46) CLK4DYRK1AMAPK1TNFNOD1
SCHEMBL2368514 0.89 CLK4 (0.44) CLK4DYRK1AMAPK1TNFNOD1
SCHEMBL2368728 0.88 MAPK1 (0.49) CLK4DYRK1AMAPK1TNFNOD1
SCHEMBL6360615 0.86 CLK4 (0.47) CLK4DYRK1AMAPK1TNFNOD1
SCHEMBL2369182 0.85 CLK4 (0.52) CLK4DYRK1AMAPK1TNFNOD1
SCHEMBL2368286 0.83 CLK4 (0.49) CLK4DYRK1AMAPK1TNFNOD1
SCHEMBL2368531 0.83 CLK4 (0.49) CLK4DYRK1AMAPK1TNFNOD1
SCHEMBL2368451 0.82 MAPK1 (0.69) CLK4DYRK1AMAPK1TNFNOD1
SCHEMBL3384571 0.81 CLK4 (0.46) CLK4DYRK1AMAPK1TNFNOD1
SCHEMBL2369121 0.81 CLK4 (0.47) CLK4DYRK1AMAPK1TNFNOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050026935-A1 Compounds XENTION DISCOVERY LTD. 2005-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026935-A1 Compounds KCNJ11, KCNJ1, KCNH1 CLK4 3399/4885DYRK1A 4617/4885MAPK1 667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.